Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOP-ART: Trauma Organ Protection with Artesunate
ISRCTN15731357Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Mar 2017
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of artesunate in Bleeding and multiple organ dysfunction syndrome (MODS) (4 arms), sponsored by Queen Mary University of London. Primary endpoint: Sequential Organ Failure Assessment score at 48 hours. Started Mar 2017; status: completed.
02
Drugs
artesunate
03
Conditions
Bleedingmultiple organ dysfunction syndrome (MODS)
Beyond the preview
Go deeper on ISRCTN15731357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15731357.